Tag: Chemotherapy
ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
One-year progression-free survival, overall survival was 79.4, 89.6 percent; significantly longer survival seen in patients who achieved resectability
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
Significant differences seen in four of six self-reported cognitive function outcomes favoring aerobic exercise initiated with chemo
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
Findings seen in combination with chemotherapy following surgery in patients with curative intent
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
Findings seen for patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
Alternative treatments came at significantly higher costs for both payers, patients
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
Overall survival higher in group receiving pembrolizumab plus chemo versus chemotherapy alone
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate
